SPA
BLFS icon

Sherbrooke Park Advisers’s BioLife Solutions BLFS Stock Holding History

Sherbrooke Park Advisers’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,526
Closed -$356K – 531
2025
Q2 		$356K Buy
+16,526
New +$372K 0.15% 270
2025
Q1 		– Sell
-16,574
Closed -$430K – 630
2024
Q4 		$430K Sell
16,574
-6,337
-28% -$158K 0.14% 268
2024
Q3 		$574K Buy
+22,911
New +$541K 0.13% 252
2024
Q2 		– Sell
-14,348
Closed -$266K – 919
2024
Q1 		$266K Buy
+14,348
New +$251K 0.05% 614

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Sherbrooke Park Advisers's BLFS Position: Q3 2025 in Review

Sherbrooke Park Advisers sold out of BioLife Solutions (BLFS) in Q3 2025, closing a stake of 16,526 shares — an estimated $356K sold.

Sherbrooke Park Advisers first reported a position in BLFS in Q1 2024 and held it in 4 quarters. The position peaked at $574K in Q3 2024. 192 funds tracked by Wall St. Rank hold BLFS as of Q3 2025.

  • Sherbrooke Park Advisers reported no remaining BioLife Solutions position as of Q3 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 16,526 BioLife Solutions shares in Q3 2025, an estimated $356K.
  • Sherbrooke Park Advisers first reported a position in BioLife Solutions in Q1 2024 and held it in 4 quarters.
  • Sherbrooke Park Advisers's BioLife Solutions position peaked at $574K in Q3 2024.
  • 192 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.